Considerations for revision of safety information in package inserts of anti-cancer drugs in post-market phase
XIONG Weiyi, REN Jingtian
Chinese Journal of Pharmacovigilance . 2024, (1): 94 -97 .  DOI: 10.19803/j.1672-8629.20230609